CSI Market
Sign In | Register

Filana Therapeutics Inc (FLNA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access FLNA Annual Balance Sheets →
This page allows investors to track Filana Therapeutics Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent86.57
Cash & Short-term Investments86.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.39
Total Current Assets87.96
Equipment/Property/Plant Net20.40
Other Assets, Noncurrent0.00
Total Assets108.37
Liabilities
Accounts Payable and Other Accrued Liabilities, Current39.19
Employee-related Liabilities, Current AC0.25
Other Liabilities, Current0.08
Total Current Liabilities40.12
Total Long-term Debt0.00
Other liabilities, Noncurrent0.11
Accrued Development Expense Current0.61
Total Liabilities40.23
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock574.51
Retained Earnings / Accumulated Deficit-506.42
Other Equity0.00
Common Stockholder's Equity68.14
Total Stockholder's Equity68.14
Liabilities & Stockholder's Equity108.37
4 historic quarters locked

Sign in to unlock the full Filana Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Filana Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-024752

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.